SOCIETE D'EXERCICE LIBERAL UNIPERSONNELLE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICINE - PHARMACIE VAL DE CROZE : revenue, balance sheet and financial ratios

SOCIETE D'EXERCICE LIBERAL UNIPERSONNELLE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICINE - PHARMACIE VAL DE CROZE is a French company founded 12 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in MONTPELLIER (34070), this company of category PME shows in 2022 a revenue of 1.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - SOCIETE D'EXERCICE LIBERAL UNIPERSONNELLE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICINE - PHARMACIE VAL DE CROZE (SIREN 793528407)
Indicador 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Ingresos N/C N/C N/C 1 097 060 € 978 459 € N/C N/C N/C 721 503 € N/C 648 708 € 659 415 €
Resultado neto 21 738 € 27 958 € 56 418 € 177 107 € 61 308 € 81 706 € 106 406 € 82 595 € 81 601 € 79 727 € 61 944 € -33 985 €
EBITDA N/C N/C N/C 243 022 € 85 220 € N/C N/C N/C 104 261 € N/C 56 274 € -32 223 €
Margen neto N/C N/C N/C 16.1% 6.3% N/C N/C N/C 11.3% N/C 9.5% -5.2%

Ingresos y cuenta de resultados

In 2025, SOCIETE D'EXERCICE LIBERAL UNIPERSONNELLE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICINE - PHARMACIE VAL DE CROZE generates positive net income of 22 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Resultado neto (2025) ?
Resultado neto
Definición
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Fórmula
Resultado corriente + Resultado excepcional - Impuesto sobre beneficios

21 738 €

Chargement du compte de résultat...

Évolution graphique

Mostrar :

Activo

Chargement des données...

Pasivo

Chargement des données...

Ratios de solvencia y endeudamiento

The debt ratio (= Financial debt / Equity x 100) stands at 23%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 74%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Ratio de endeudamiento (2025) ?
Ratio de endeudamiento
Definición
Mide la proporción de deuda respecto a los fondos propios.
Fórmula
(Deuda financiera / Fondos propios) x 100
Interpretación
< 50% : Faible
50-100% : Moderado
> 100% : Alto

22.967%

Autonomía financiera (2025) ?
Autonomía financiera
Definición
Porcentaje de fondos propios en la financiación total.
Fórmula
(Fondos propios / Total balance) x 100
Interpretación
> 30% : Buena autonomía
20-30% : Media
< 20% : Faible

74.483%

Ratio de obsolescencia (2025) ?
Ratio de obsolescencia
Definición
Mide el grado de desgaste del inmovilizado material.
Fórmula
Amortización acumulada / Inmovilizado bruto x 100
Interpretación
< 50% : Activos recientes
50-70% : Desgaste normal
> 70% : Activos envejecidos

45.1%

Evolución de indicadores de solvencia
SOCIETE D'EXERCICE LIBERAL UNIPERSONNELLE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICINE - PHARMACIE VAL DE CROZE

Positionnement sectoriel

Debt ratio
22.97 2025
2023
2024
2025
Q1: 13.57
Méd: 49.47
Q3: 128.28
Good

In 2025, the debt ratio of SOCIETE D'EXERCICE LIBERA... (22.97) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
74.48% 2025
2023
2024
2025
Q1: 33.69%
Méd: 53.88%
Q3: 72.26%
Excellent

In 2025, the financial autonomy of SOCIETE D'EXERCICE LIBERA... (74.5%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Ratios de liquidez

The liquidity ratio (= Current assets / Current liabilities) stands at 462.39. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Ratio de liquidez (2025) ?
Ratio de liquidez
Definición
Capacidad para pagar las deudas a corto plazo con el activo circulante.
Fórmula
Activo circulante / Pasivo circulante
Interpretación
> 1.5 : Muy bueno
1-1.5 : Correcto
< 1 : Risque de liquidité

462.393

Evolución de indicadores de liquidez
SOCIETE D'EXERCICE LIBERAL UNIPERSONNELLE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICINE - PHARMACIE VAL DE CROZE

Positionnement sectoriel

Liquidity ratio
462.39 2025
2023
2024
2025
Q1: 131.48
Méd: 182.6
Q3: 258.72
Excellent

In 2025, the liquidity ratio of SOCIETE D'EXERCICE LIBERA... (462.39) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Necesidad de fondo de rotación (NFR) y plazos de pago

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

NFR de explotación (2025) ?
NFR de explotación
Definición
Besoin de financement généré par le cycle d'exploitation (stocks + créances - dettes fournisseurs).
Fórmula
Stocks + Créances clients - Dettes fournisseurs
Interpretación
Negativo = tesorería liberada
Positivo = necesidad de financiación

0 €

Crédito clientes (2025) ?
Crédito clientes (días)
Definición
Plazo medio de cobro a clientes.
Fórmula
(Cuentas por cobrar / Ingresos con IVA) x 360
Interpretación
< 45j : Bueno
45-60j : Medio
> 60j : Largo

0 j

Crédito proveedores (2025) ?
Crédito proveedores (días)
Definición
Plazo medio de pago a proveedores.
Fórmula
(Cuentas por pagar / Compras con IVA) x 360
Interpretación
Cuanto más largo sea el plazo, mejor para la tesorería

0 j

Rotación de inventario (2025) ?
Rotación de inventario (días)
Definición
Duración media de almacenamiento de mercancías o materiales.
Fórmula
(Existencias / Coste de compra) x 360
Interpretación
Cuanto menor sea el ratio, más rápida es la rotación

0 j

Evolución del NFR y plazos
SOCIETE D'EXERCICE LIBERAL UNIPERSONNELLE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICINE - PHARMACIE VAL DE CROZE

Positionnement de SOCIETE D'EXERCICE LIBERAL UNIPERSONNELLE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICINE - PHARMACIE VAL DE CROZE dans son secteur

Comparación con el sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Estimación de valoración

Based on 277 transactions of similar company sales in 2025, the value of SOCIETE D'EXERCICE LIBERAL UNIPERSONNELLE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICINE - PHARMACIE VAL DE CROZE is estimated at 345 310 € (range 234 329€ - 541 840€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
234k€ 345k€ 541k€
345 310 € Range: 234 329€ - 541 840€
NAF 5 année 2025

Valuation method used

Net Income Multiple
21 738 € × 15.9x = 345 311 €
Range: 234 329€ - 541 840€

Only this financial indicator is available for this company.

Evolución de la valoración

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SOCIETE D'EXERCICE LIBERAL UNIPERSONNELLE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICINE - PHARMACIE VAL DE CROZE with other companies in the same sector:

Frequently asked questions about SOCIETE D'EXERCICE LIBERAL UNIPERSONNELLE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICINE - PHARMACIE VAL DE CROZE

What is the revenue of SOCIETE D'EXERCICE LIBERAL UNIPERSONNELLE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICINE - PHARMACIE VAL DE CROZE ?

The revenue of SOCIETE D'EXERCICE LIBERAL UNIPERSONNELLE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICINE - PHARMACIE VAL DE CROZE in 2022 is 1.1 M€.

Is SOCIETE D'EXERCICE LIBERAL UNIPERSONNELLE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICINE - PHARMACIE VAL DE CROZE profitable?

Yes, SOCIETE D'EXERCICE LIBERAL UNIPERSONNELLE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICINE - PHARMACIE VAL DE CROZE generated a net profit of 22 k€ in 2025.

Where is the headquarters of SOCIETE D'EXERCICE LIBERAL UNIPERSONNELLE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICINE - PHARMACIE VAL DE CROZE ?

The headquarters of SOCIETE D'EXERCICE LIBERAL UNIPERSONNELLE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICINE - PHARMACIE VAL DE CROZE is located in MONTPELLIER (34070), in the department Herault.

Where to find the tax return of SOCIETE D'EXERCICE LIBERAL UNIPERSONNELLE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICINE - PHARMACIE VAL DE CROZE ?

The tax return of SOCIETE D'EXERCICE LIBERAL UNIPERSONNELLE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICINE - PHARMACIE VAL DE CROZE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SOCIETE D'EXERCICE LIBERAL UNIPERSONNELLE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICINE - PHARMACIE VAL DE CROZE operate?

SOCIETE D'EXERCICE LIBERAL UNIPERSONNELLE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICINE - PHARMACIE VAL DE CROZE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.